Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

被引：104
|
作者：
Choo, Eun Ju [1 ]
Chambers, Henry F. [2 ]
机构：
[1] Soonchunhyang Univ Hosp, Dept Med, Div Infect Dis, Bucheon, South Korea
[2] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA
来源：
INFECTION AND CHEMOTHERAPY | 2016年 / 48卷 / 04期
关键词：
Methicillin-resistant Staphylcoccus aureus; Vancomycin; Treatment;
D O I：
10.3947/ic.2016.48.4.267
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of health care-associated infections. Vancomycin remains an acceptable treatment option. There has been a welcome increase in the number of agents available for the treatment of MRSA infection. These drugs have certain differentiating attributes and may offer some advantages over vancomycin, but they also have significant limitations. These agents provide some alternative when no other options are available.
引用
收藏
页码：267 / 273
页数：7
相关论文
共 50 条
  • [31] Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis
    Marty, FM
    Yeh, WW
    Wennersten, CB
    Venkataraman, L
    Albano, E
    Alyea, EP
    Gold, HS
    Baden, LR
    Pillai, SK
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (02) : 595 - 597
  • [32] Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia
    Soriano, Alex
    Marco, Francesc
    Martinez, Jose A.
    Pisos, Elena
    Almela, Manel
    Dimova, Veselka P.
    Alamo, Dolores
    Ortega, Mar
    Lopez, Josefina
    Mensa, Josep
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 (02) : 193 - 200
  • [33] Daptomycin in Combination With Other Antibiotics for the Treatment of Complicated Methicillin-Resistant Staphylococcus aureus Bacteremia
    Dhand, Abhay
    Sakoulas, George
    [J]. CLINICAL THERAPEUTICS, 2014, 36 (10) : 1303 - 1316
  • [34] Risk Factors for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Despite Treatment With Vancomycin
    Bessette, Erika
    Ahern, John
    Alston, W.
    [J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2007, 15 (03) : 174 - 177
  • [35] Persistent bacteremia due to methicillin-resistant Staphylococcus aureus. A result of inadequate treatment
    Parra-Ruiz, Jorge
    Tomas-Jimenez, Cristina
    Munoz-Medina, Leopoldo
    Hernandez-Quero, Jose
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2009, 27 (06): : 372 - 373
  • [36] Methicillin-resistant Staphylococcus aureus
    Turner, Evie
    Brownlee, Keith G.
    Denton, Miles
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (02) : 184 - 185
  • [37] Methicillin-resistant Staphylococcus aureus
    Lee, Andie S.
    de Lencastre, Herminia
    Garau, Javier
    Kluytmans, Jan
    Malhotra-Kumar, Surbhi
    Peschel, Andreas
    Harbarth, Stephan
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2018, 4
  • [38] Methicillin resistant Staphylococcus aureus bacteremia
    De Araujo Otero, Stephanie
    Lagrutta, Mariana
    Negro Marquinez, Liliana
    Paro-Di, Roberto
    Perez, Jorgelina
    Falco, Gabriela
    Greca, Alcides
    [J]. REVISTA MEDICA DE ROSARIO, 2019, 85 (03): : 113 - 125
  • [39] Methicillin-resistant Staphylococcus aureus
    Gosbell, IB
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2004, 5 (04) : 239 - 259
  • [40] Methicillin-resistant Staphylococcus aureus
    Losa, JE
    Barba, R
    Delgado-Iribarren, A
    [J]. MEDICINA CLINICA, 2002, 119 (19): : 755 - 756
12345